These Are The Worst 25 Stocks to Own in February [Yahoo! Finance]
Biogen Inc. (BIIB)
Last biogen inc. earnings: 4/22 07:12 am
Check Earnings Report
US:NASDAQ Investor Relations:
biogen.com/en_us/investors.html
Company Research
Source: Yahoo! Finance
The market managed monthly wins in January , but as we get into February, it's not a bad idea to keep an eye on stocks that have had a tendency to underperform. For your convenience, Schaeffer's Senior Quantitative Analyst Rocky White compiled a list of the 25 worst stocks on the S&P 500 over the last decade. Biogen Inc (NASDAQ:BIIB) is one of the worst stocks on the list. Per White, BIIB averages a February loss of 4.2% over the past 10 years, and has finished the month positive only two times. A couple other pharma stocks landed on the list as well: Pfizer (PFE) and Vertex Pharmaceuticals (VRTX). BIIB has been climbing since Jan. 20, but a February drop could bring it right back down toward support at the $160 level. Watch out for post-earnings volatility, however, as the company is set to announce its fourth-quarter results before the open on Friday, Feb. 6. The stock finished five of its last eight post-earnings sessions lower, including a 4.3% gap lower last February. Ahead
Show less
Read more
Impact Snapshot
Event Time:
BIIB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BIIB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIIB alerts
High impacting Biogen Inc. news events
Weekly update
A roundup of the hottest topics
BIIB
News
- Biogen (NASDAQ:BIIB) was given a new $191.00 price target on by analysts at Sanford C. Bernstein.MarketBeat
- Biogen (NASDAQ:BIIB) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..MarketBeat
- Lupus Research Alliance Applauds U.S. FDA Breakthrough Therapy Designation for Litifilimab in Cutaneous Lupus Erythematosus [Yahoo! Finance]Yahoo! Finance
- Biogen’s Litifilimab Receives FDA Breakthrough Therapy Designation for Cutaneous Lupus Erythematosus, a Disease With No Targeted Treatment OptionsGlobeNewswire
- Biogen (NASDAQ:BIIB) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..MarketBeat
BIIB
Earnings
- 10/31/25 - Beat
BIIB
Sec Filings
- 2/3/26 - Form 4
- 2/2/26 - Form 144
- 1/14/26 - Form 8-K
- BIIB's page on the SEC website